|
|
|
| Research Article Online Published: 06 Feb 2024 | ||
J Med Res Rev. 2024; 2(1): 21-29 *+*00-jmrr-2-21/jmrr-2-21.html-11*+* | ||
| How to Cite this Article |
| Pubmed Style Ishaq M, Afsar NA, Riaz SU, Abbas M, Mukarram MS, Ishaq K, Ishaq S, Ali MS. Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia. J Med Res Rev. 2024; 2(1): 21-29. doi:10.5455/JMRR.20231226053523 Web Style Ishaq M, Afsar NA, Riaz SU, Abbas M, Mukarram MS, Ishaq K, Ishaq S, Ali MS. Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia. https://www.wisdomgale.com/jmrr/?mno=182674 [Access: January 28, 2026]. doi:10.5455/JMRR.20231226053523 AMA (American Medical Association) Style Ishaq M, Afsar NA, Riaz SU, Abbas M, Mukarram MS, Ishaq K, Ishaq S, Ali MS. Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia. J Med Res Rev. 2024; 2(1): 21-29. doi:10.5455/JMRR.20231226053523 Vancouver/ICMJE Style Ishaq M, Afsar NA, Riaz SU, Abbas M, Mukarram MS, Ishaq K, Ishaq S, Ali MS. Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia. J Med Res Rev. (2024), [cited January 28, 2026]; 2(1): 21-29. doi:10.5455/JMRR.20231226053523 Harvard Style Ishaq, M., Afsar, . N. A., Riaz, . S. U., Abbas, . M., Mukarram, . M. S., Ishaq, . K., Ishaq, . S. & Ali, . M. S. (2024) Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia. J Med Res Rev, 2 (1), 21-29. doi:10.5455/JMRR.20231226053523 Turabian Style Ishaq, Muhammad, Nasir Ali Afsar, Syeda Urooj Riaz, Muslim Abbas, Muhammad Shariq Mukarram, Khizra Ishaq, Shifa Ishaq, and Muhammad Sanowar Ali. 2024. Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia. Journal of Medical Research and Reviews, 2 (1), 21-29. doi:10.5455/JMRR.20231226053523 Chicago Style Ishaq, Muhammad, Nasir Ali Afsar, Syeda Urooj Riaz, Muslim Abbas, Muhammad Shariq Mukarram, Khizra Ishaq, Shifa Ishaq, and Muhammad Sanowar Ali. "Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia." Journal of Medical Research and Reviews 2 (2024), 21-29. doi:10.5455/JMRR.20231226053523 MLA (The Modern Language Association) Style Ishaq, Muhammad, Nasir Ali Afsar, Syeda Urooj Riaz, Muslim Abbas, Muhammad Shariq Mukarram, Khizra Ishaq, Shifa Ishaq, and Muhammad Sanowar Ali. "Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia." Journal of Medical Research and Reviews 2.1 (2024), 21-29. Print. doi:10.5455/JMRR.20231226053523 APA (American Psychological Association) Style Ishaq, M., Afsar, . N. A., Riaz, . S. U., Abbas, . M., Mukarram, . M. S., Ishaq, . K., Ishaq, . S. & Ali, . M. S. (2024) Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia. Journal of Medical Research and Reviews, 2 (1), 21-29. doi:10.5455/JMRR.20231226053523 |
